IndraLab

Statements

Teriflunomide inhibits NFKBIA. 1 / 1

| 1

reach

"NF-kappaB pathway inhibition improved response and survival in EGFR-mutant lung cancer patients treated with EGFR TKI (Bivona et al., 2011), our studies found that NFKBIA (NFKB inhibitor alpha) and NF[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

29050931

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Teriflunomide inhibits NFKBIA. 1 / 1

INDRA sources:

Databases

Reading